Insulet Executive and Leadership Team

Ashley McEvoy, the Director, President & Chief Executive Officer at Insulet, directs the overarching corporate strategy and long-term vision for the medical device portfolio. Overseeing global operations, the Director, President & Chief Executive Officer ensures the Omnipod platform maintains market leadership while driving expansion into new therapeutic areas. This executive role involves constant collaboration with the Board to align product development with patient needs and financial performance targets. By prioritizing innovation in wearable technology, Ashley McEvoy directly influences the company's ability to simplify insulin delivery for millions. McEvoy manages the integration of advanced manufacturing processes with patient-centric design, ensuring that the organization remains at the forefront of the medical device industry. Through rigorous focus on operational excellence, the Director, President & Chief Executive Officer secures sustainable growth and enhances the quality of life for individuals managing diabetes.

Carsten Boess, the Chief Financial Officer at Insulet, manages the fiscal health and capital allocation strategies necessary to support large-scale manufacturing of the Omnipod system. Overseeing financial planning and analysis, the Chief Financial Officer ensures that resource distribution aligns with the company's aggressive growth objectives in the medical device sector. This leadership role involves maintaining robust internal controls and providing transparent reporting to stakeholders regarding the financial impact of global market expansion. By optimizing the cost structure of the disposable Pod production, Carsten Boess directly supports the scalability of the business model. Boess coordinates with other C-suite leaders to evaluate investment opportunities in new subcutaneous drug delivery technologies. Ultimately, the Chief Financial Officer maintains the financial stability required to sustain long-term research and development initiatives while navigating the complexities of the international healthcare market.

Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, directs the treasury functions and capital structure to support the company's mission of advancing medical device technology. Overseeing financial risk management, the Executive Vice President & Chief Financial Officer & Treasurer ensures liquidity and funding for the manufacturing of the Omnipod system. This leadership role involves managing investor relations and executing financial strategies that facilitate global market penetration. By optimizing the balance sheet, Ana Chadwick directly impacts the company's capacity to invest in new therapeutic areas and subcutaneous drug delivery platforms. Chadwick collaborates with the Board to ensure fiscal discipline while pursuing aggressive innovation goals. Through strategic oversight of financial assets, the Executive Vice President & Chief Financial Officer & Treasurer secures the necessary capital to maintain the company's competitive edge in the medical device industry.

Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc at Insulet, manages the financial reporting and accounting standards that underpin the company's operational success in the medical device market. Overseeing the financial integrity of the organization, the Chief Financial Officer, At Alcon Inc ensures compliance with regulatory requirements while supporting the manufacturing of the Omnipod system. This leadership role involves analyzing cost-efficiency across the supply chain to maximize profitability. By monitoring financial performance metrics, Timothy Stonesifer directly contributes to the strategic decision-making process regarding resource allocation. Stonesifer works closely with the finance department to refine budgeting processes and improve the accuracy of financial forecasting. Through rigorous oversight, the Chief Financial Officer, At Alcon Inc provides the necessary financial foundation to support the company's mission of simplifying insulin delivery and expanding into diverse therapeutic markets.

Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, architects the end-to-end customer experience framework to ensure seamless interaction with the Omnipod platform. Overseeing operational workflows, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) aligns internal processes with the needs of patients and healthcare providers. This leadership role involves streamlining communication channels and optimizing service delivery to enhance user satisfaction across North American and international markets. By integrating data-driven insights into daily operations, Nikkole DeMars directly improves the efficiency of the customer support ecosystem. DeMars coordinates cross-functional teams to resolve complex service challenges, ensuring that the company's commitment to simplifying diabetes management remains consistent. Through meticulous planning, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) drives operational excellence and strengthens the overall brand reputation.

Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, architects the digital infrastructure and cloud-based data solutions that power the Omnipod platform. Overseeing software development, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products ensures that data connectivity remains secure and reliable for patients managing diabetes. This leadership role involves integrating advanced analytics into the product ecosystem to improve patient outcomes and device performance. By driving the evolution of cloud data products, Rakesh Pant directly enhances the functionality of the wearable technology. Pant coordinates with engineering teams to implement scalable software solutions that support the company's expansion into new therapeutic areas. Through technical innovation, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products maintains the integrity of the digital platform and ensures that the company remains a leader in connected medical devices.

Trang Ly, the Senior Vice President, Chief Medical Officer at Insulet, directs the clinical research and medical strategy that validate the efficacy of the Omnipod platform. Overseeing clinical trials, the Senior Vice President, Chief Medical Officer ensures that all product developments meet the highest standards of patient safety and medical necessity. This leadership role involves engaging with the medical community to promote the adoption of wearable insulin delivery systems. By translating clinical data into actionable product improvements, Trang Ly directly enhances the therapeutic impact of the company's devices. Ly collaborates with regulatory bodies to secure approvals for new applications of the Omnipod technology in other therapeutic areas. Through scientific leadership, the Senior Vice President, Chief Medical Officer drives the company's commitment to improving the lives of people with diabetes and other conditions through evidence-based medical innovation.